{"id":"W2037647430","doi":"10.1007/s10637-005-2907-z","title":"A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Pharmacokinetics; Neutropenia; Cancer; Nausea; Toxicity; Population; Phases of clinical research; Internal medicine; Gastroenterology; Vomiting; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405813,0.001785725,0.003203537,0.0005078541,0.0005665784,0.001013614,0.001027307,0.00125679,0.002757508],"category_scores_gemma":[0.001328805,0.0009950512,0.001211326,0.0005818767,0.001658943,0.001413272,0.0004423707,0.003961256,0.0008594098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001310802,"about_ca_system_score_gemma":0.002086879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002345968,"about_ca_topic_score_gemma":0.00429555,"domain_scores_codex":[0.9991924,0.0004123898,0.00002640898,0.0001347564,0.00006763142,0.0001663036],"domain_scores_gemma":[0.9989645,0.0001802844,0.0001614714,0.0001167967,0.00004568348,0.0005311365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7261634,0.1044808,0.0220039,0.0003457446,0.001221084,0.0005421893,0.0004677987,0.004043724,0.05326904,0.0003978521,0.00285217,0.08421238],"study_design_scores_gemma":[0.4040455,0.5490877,0.03661223,0.00001706717,0.0004861161,0.0005182576,0.0001411681,0.002286025,0.004311758,0.0001818366,0.002251684,0.00006063638],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969544,0.0005640632,0.0003153555,0.000201411,0.00004245784,0.0006607189,0.0004371366,0.00003860558,0.0007858628],"genre_scores_gemma":[0.9941094,0.0008500792,0.001116449,0.0004326325,0.0001295203,0.0007677848,0.001252788,0.00003397627,0.001307484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003203537,"threshold_uncertainty_score":0.009510517,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0318275384668315,"score_gpt":0.3383269827617641,"score_spread":0.3064994442949326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}